A 75-Year-Old Woman with Muscle-Invasive Bladder Cancer - Episode 5

CheckMate 274: Data Updates in MIBC from GU ASCO, ASCO, and ESMO 2022

Terence Friedlander, MD, continues his discussion of the CheckMate 247 trial by highlighting important updates from recent conferences on adjuvant nivolumab therapy in patients with MIBC.

EP. 1: Case Presentation: A 75-Year-Old Woman with Muscle-Invasive Bladder Cancer (MIBC)
EP. 2: Eligibility for Cisplatin Therapy in Patients with MIBC
EP. 3: Available Adjuvant Therapy Options for Patients with Stage II or III MIBC after Cystectomy
EP. 4: Adjuvant Nivolumab Therapy for MIBC: Safety and Efficacy Data from CheckMate 274
Now Viewing
EP. 5: CheckMate 274: Data Updates in MIBC from GU ASCO, ASCO, and ESMO 2022
EP. 6: Factors for Consideration when Choosing an Adjuvant Therapy Regimen for Patients with MIBC
EP. 7: Critical Unmet Needs for Patients with MIBC
EP. 8: The Future of Neoadjuvant Immunotherapy in MIBC